METAB-BELGROWMetabolic Outcomes in Belgian Children with Growth Hormone Deficiency

The study focuses on Belgian children who have a condition called growth hormone deficiency (GHD), which affects their growth and development. The goal is to understand how different types of growth hormone treatments impact the children's metabolism over three years. Some children will receive daily doses of recombinant human growth hormone (rhGH), while others will be treated with a long-acting form given weekly. The research aims to compare these two treatment methods to see which one might offer better outcomes in terms of metabolic health. This study is important as it could help determine the most effective treatment approach for children with GHD, potentially leading to better growth and health. Participants in the study will attend regular follow-up visits every 6 to 12 months, where various health parameters will be recorded. These include clinical assessments, measurements of growth, and biological tests. Additional tests will check for metabolic markers and other health indicators. In some cases, more detailed examinations like DEXA scans to look at body fat and tests to measure the thickness of artery walls will be conducted. These assessments will help researchers understand the effects of the treatments on the children's overall health and growth. The study will also monitor any potential risks or side effects of the treatments.